The AIDS Immunopathogenesis Unit, based at Instituto de Salud Carlos III, offers a group of patented (Publication number WO2005/108588) HIV-based recombinant viral vectors with proven utility to evaluate the following aspects related to HIV-1 infection:

The assays with these constructs are really competitive (cheaper, quicker and very reliable).

Besides this technical platform, we have generated a large collection of recombinant HIV-1 clones with specific characteristics regarding tropism and resistance to different antiretroviral drugs that are very valuable.

Trained technical personnel and senior researchers that work in the lab continuously improve these techniques. A large set of publications has been produced describing the different applications of this technology and validation of the different tests.

For more information on the patent, click on the link above:

For more information or budget request please fill this form or send an email to This email address is being protected from spambots. You need JavaScript enabled to view it.


We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site